267.25
Schlusskurs vom Vortag:
$275.13
Offen:
$276.96
24-Stunden-Volumen:
827.55K
Relative Volume:
1.40
Marktkapitalisierung:
$21.52B
Einnahmen:
$21.46B
Nettoeinkommen (Verlust:
$2.65B
KGV:
13.90
EPS:
19.2312
Netto-Cashflow:
$3.35B
1W Leistung:
+1.32%
1M Leistung:
+0.55%
6M Leistung:
+39.19%
1J Leistung:
+34.21%
Tenet Healthcare Corp Stock (THC) Company Profile
Firmenname
Tenet Healthcare Corp
Sektor
Branche
Telefon
469-893-2200
Adresse
14201 DALLAS PARKWAY, DALLAS, TX
Compare THC vs HCA, EHC, DVA, FMS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
THC
Tenet Healthcare Corp
|
267.25 | 21.52B | 21.46B | 2.65B | 3.35B | 19.23 |
|
HCA
Hca Healthcare Inc
|
458.84 | 99.34B | 76.39B | 7.81B | 7.93B | 29.08 |
|
EHC
Encompass Health Corp
|
127.87 | 12.61B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
DVA
Davita Inc
|
187.31 | 11.95B | 13.84B | 1.10B | 1.49B | 10.42 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.17 | 11.80B | 22.44B | 1.35B | 2.03B | 1.9002 |
Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-23 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-02-26 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-16 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-22 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Eingeleitet | JP Morgan | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-03-29 | Eingeleitet | Wells Fargo | Overweight |
| 2022-02-10 | Hochstufung | UBS | Neutral → Buy |
| 2022-02-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-02-09 | Hochstufung | Truist | Hold → Buy |
| 2022-01-20 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Neutral |
| 2021-08-12 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-23 | Fortgesetzt | Citigroup | Buy |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-03 | Fortgesetzt | Goldman | Buy |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-15 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-11 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-26 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-12-09 | Hochstufung | UBS | Neutral → Buy |
| 2019-11-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-08-14 | Fortgesetzt | Goldman | Neutral |
| 2019-02-26 | Bestätigt | BofA/Merrill | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-12-17 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-06-29 | Herabstufung | Jefferies | Buy → Hold |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-30 | Fortgesetzt | Wells Fargo | Market Perform |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-19 | Bestätigt | Mizuho | Neutral |
| 2017-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Tenet Healthcare Corp Aktie (THC) Neueste Nachrichten
Why Tenet Healthcare (THC) Outpaced the Stock Market Today - Zacks Investment Research
Tenet Healthcare (THC) Beats Stock Market Upswing: What Investors Need to Know - Zacks Investment Research
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term - Zacks Investment Research
Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research
Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know - Zacks Investment Research
Can THC's Cash Flow Support Its Expanding Capital-Return Strategy? - Zacks Investment Research
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock - Zacks Investment Research
Is Tenet Healthcare Corporation (THC) A Solid Play on Expanding Ambulatory Business? - Yahoo Finance
Tenet Healthcare prices $2B in senior notes to refinance debt - Dealroom
Tenet Healthcare Prices $2 Billion 6.250% Senior Notes Due 2034 - Minichart
New 2034 debt deal reshapes Tenet Healthcare (NYSE: THC) bonds - Stock Titan
Can Pediatrix Sustain Growth Despite Lower Patient Volumes? - Zacks Investment Research
Tenet Healthcare Director Nadja West Sells 1,152 Shares - The Motley Fool
Why Is Tenet Healthcare (NYSE:THC) Drawing Fresh Attention? - Kalkine Media
THC6508428 Bond Profile — Key Metrics - TradingView
THC6508428 Bond Yield and Price — FINRA:THC6508428 - TradingView
Tenet Health 1,500 Layoffs Ripple Across North Texas Job Market - usaherald.com
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
Tenet subsidiary to cut 1K-plus jobs tied to expected departure of major customer - WFAA
Tenet subsidiary to cut 1K-plus jobs tied to expected departure of major customer - Yahoo Finance
BlackRock, Inc. Trims Tenet Healthcare Corp (THC) Stake -- Shares Look 42% Overvalued on GF Value - GuruFocus
11th Circ. Urged To Undo Trial Loss For Hospital Ratings Org - Law360
Tenet Healthcare (NYSE: THC) director lines up 10,000-share Rule 144 sale - Stock Titan
Tenet subsidiary to cut 1K-plus jobs tied to expected departure of major customer - The Business Journals
Is Tenet Healthcare Corp (THC) Overvalued After 3.9% Rally? GF V - GuruFocus
Tenet Healthcare rises as refinancing plan and upbeat conference messaging lift sentiment - Quiver Quantitative
Three North Texas companies announce nearly 1,500 layoffs - Dallas News
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
Tenet Healthcare (NYSE: THC) Plans $2 Billion 6.250% Senior Notes Offering Closing on September 22, 2026 - Kalkine Media
Tenet Healthcare at Wells Fargo conference: high-acuity push deepens - investing.com
Tenet Healthcare at Wells Fargo conference: high-acuity push deepens By Investing.com - Investing.com UK
Tenet Healthcare Launches $1.5 Billion Notes Offering to Refinance 2027 Debt - Minichart
Tenet Healthcare prices $2 billion senior notes offering By Investing.com - Investing.com India
Tenet Healthcare prices $2 billion senior notes offering - investing.com
Tenet Healthcare prices $2 billion senior notes offering By Investing.com - Investing.com UK
Tenet Healthcare prices $2.0B 6.25% senior notes due 2034, upsizes offering to refinance 2027 and 2028 notes - TradingView
Tenet Healthcare (NYSE: THC) reshapes $2.0B in debt - Stock Titan
Tenet Announces Upsizing and Pricing of Its $2.0 Billion Private Offering of Senior Notes - Yahoo Finance
THC Looks 42.8% Overvalued on GF Value™ - GuruFocus
Tenet Healthcare offers $1.5B notes to refinance 2027 debt - investing.com
Tenet Healthcare offers $1.5B notes to refinance 2027 debt By Investing.com - Investing.com India
Tenet could refinance $1.5B due in 2027 with notes due in 2034. - Stock Titan
ETFs Investing in Tenet Healthcare Corporation Stocks - TradingView
HCA Healthcare Inc. stock underperforms Friday when compared to competitors - MarketWatch
BlackRock controls millions of Tenet Healthcare (NYSE: THC) shares, but how much voting power is solely its own? - Stock Titan
Tenet Healthcare (THC), What Is Behind The Fresh Attention? - Yahoo Finance
Tenet Healthcare (NYSE:THC) Looks Like a Decent Value Stock With Strong Profitability - ChartMill
Tenet Healthcare director Nadja West sells $298,137 in stock By Investing.com - Investing.com Australia
Tenet Healthcare director Nadja West sells $298,137 in stock - investing.com
Tenet Healthcare director Nadja West sells $298,137 in stock By Investing.com - Investing.com Nigeria
Finanzdaten der Tenet Healthcare Corp-Aktie (THC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tenet Healthcare Corp-Aktie (THC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| KERREY J ROBERT | Director |
Sep 14 '26 |
Proposed Sale |
267.50 |
12,010 |
3,212,675 |
0 |
| MARK RICHARD J | Director |
Sep 10 '26 |
Sale |
263.42 |
10,000 |
2,634,200 |
25,121 |
| MARK RICHARD J | Director |
Sep 10 '26 |
Proposed Sale |
263.42 |
10,000 |
2,634,155 |
0 |
| West Nadja | Director |
Sep 02 '26 |
Sale |
258.80 |
1,152 |
298,138 |
23,653 |
| West Nadja | Director |
Sep 02 '26 |
Proposed Sale |
258.80 |
1,152 |
298,138 |
0 |
| Foo Lisa Y | EVP, Chief Operating Officer |
Aug 31 '26 |
Sale |
266.32 |
24,000 |
6,391,680 |
8,053 |
| Foo Lisa Y | Officer |
Aug 31 '26 |
Proposed Sale |
266.32 |
24,000 |
6,391,579 |
0 |
| Sutaria Saumya | CEO |
Aug 25 '26 |
Sale |
274.02 |
50,000 |
13,701,076 |
433,564 |
| Sutaria Saumya | Officer |
Aug 25 '26 |
Proposed Sale |
274.02 |
50,000 |
13,701,028 |
0 |
| Sutaria Saumya | Officer |
Aug 24 '26 |
Proposed Sale |
278.70 |
50,000 |
13,935,240 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):